medical billing at home

	Medical Billing At Home Medical Billing Course Medical Billing And Coding Training Medical Billing Coding
	Medical Billing Lytec Medical Medical Billing And Coding Schools Practice Performance Billing Service Bloomington Medical Billing Medical Billing College Electronic Medical Billing Chiropractic Billing Services Centers For Medicre Medical Billing And Coding Classes Medisoft Medical Insurance Billing Services Medical Billing Cpt Medical Practice Management Software Medical Billing At Home Medical Biller Medical Billing And Coding Specialist Medical Billing And Coding Certification

	Most Older AML Patients May Want to Skip Intensive Chemo (CME/CE) (MedPage Today) -- The majority of patients 70 and older who have acute myeloid leukemia (AML) may not benefit from intensive chemotherapy, a single-center study showed. Male Breast CA Rare, but a Worry for Families (CME/CE, with audio) (MedPage Today) -- Having a male relative with breast cancer boosts the family's perception of their own risk but doesn't help the odds that they will do something about it, analysis of national survey data showed. Bone Density May Predict Prostate Cancer in Old Age (CME/CE) (MedPage Today) -- Bone scans might help identify men at high risk for aggressive prostate tumors as they age, researchers said. Ablate and Wait in Liver CA, Experts Suggest (CME/CE) (MedPage Today) -- Outcomes in all patients with hepatocellular carcinoma might improve with an "ablate-and-wait" strategy versus rapid transplantation, according to a group of clinicians who have regularly used the strategy. Test Predicts Kinase Inhibitor Resistance in CML (CME/CE) (MedPage Today) -- A novel laboratory test may accurately distinguish which chronic myeloid leukemia (CML) patients will develop resistance to imatinib (Gleevec), researchers said. Immunotherapy Shows Benefit in Prostate CA (CME/CE) (MedPage Today) -- A cellular immunotherapy appears to prolong survival among men with metastatic castration-resistant prostate cancer, researchers reported. Virtual Colonoscopy Misses Mark on Cost (CME/CE) (MedPage Today) -- Virtual colonoscopy is cost-effective only when priced lower than conventional colonoscopy or if it attracts a large unscreened population, according to computer models of colon cancer screening strategies. Risk Predictor Works for ER Positive Breast CA (CME/CE) (MedPage Today) -- A risk score based on a number of uncommon genetic variants appears to predict risk of estrogen receptor-positive breast cancer but with questionable clinical utility, researchers said. Breast Tumors Harder to Find in Younger Women (CME/CE) (MedPage Today) -- Women in their 40s with breast cancer have tumors that are more difficult to detect with mammography, not faster growing tumors that manifest between screenings, a computer simulation of breast cancer suggests. PSA Screening Can Lead to Overtreatment (CME/CE, with video) (MedPage Today) -- Many men being treated aggressively for low-grade prostate cancer -- particularly if it was detected during prostate-specific antigen screening -- are unlikely to benefit from the intervention, a new study suggests. Childhood Cancer Leaves Cardiac Legacy (CME/CE) (MedPage Today) -- An alarmingly high percentage of childhood cancer survivors have abnormal cardiac function even in early adulthood, a long-term Dutch study found. Gene Probes Show Promise for Lung Cancer Diagnosis (CME/CE, with audio) (MedPage Today) -- Patients with non-small cell lung cancer (NSCLC) had significantly higher levels of circulating genetically abnormal cells compared with cancer-free patients -- suggesting that a DNA-based test might be valuable for early diagnosis, according to data from an initial clinical study. Gene Therapy Benefits Persist in SCID (CME/CE) (MedPage Today) -- Gene therapy appears to have long-term success for treating X-linked severe combined immunodeficiency disease (SCID) -- but recipients are at risk for acute leukemia, according to a small study from France. Add-On Therapy Safe in NSCLC (CME/CE) (MedPage Today) -- Adding bevacizumab (Avastin) to standard chemotherapy appears to be generally safe for treating patients with advanced nonsquamous non-small cell lung cancer (NSCLC), according to data from a large multinational clinical trial. FDA Panel Nixes Bevacizumab for Breast Cancer (MedPage Today) -- GAITHERSBURG, Md. -- An advisory panel has voted 12 to 1 to recommend that the FDA remove the advanced breast cancer indication from bevacizumab (Avastin), after two large clinical trials failed to demonstrate a clinically meaningful benefit of the drug, which carries serious side effects.

medical billing at home guide

Onlinemedicalbilling-24
By Mike
Article Body: According to the Bureau of Labor Statistics of the US Government, there is a tendency for the and coding to achieve a faster growth than any other occupation through the year two thousand fourteen. There is a great demand for skilled medical billers and coders in the United States in the light of the fact that the health care sector has a vast potential for growth. Online courses are on offer to prepare students for such jobs. Therefore, if you have a desire, it is worth your while to carry out some searching on the Internet for online courses. It is of benefit to debate the pros and cons of following an online course before really taking the plunge. Rather than enrolling for a college course, an online course is less expensive. You always find the classrooms filled with students whereas you are on your own when studying online which gives you the much needed room for better concentration on studies. No expenses are incurred with travelling to and fro classes. The saving on your much-needed cash

Washington Week: Nonstop Action As FDA Closes Out July
WASHINGTON (MedPage Today) -- It's been an unusually hectic July for the FDA, and this past week was no exception. The agency approved a polypill to treat hypertension, and separate FDA advisory committees endorsed an investigational antiplatelet, grappled with safety issues involving a new spine device, and debated when it's okay to change endpoints in clinical trials.
FDA Panel Grapples With Changing Study Endpoint
ADELPHI, Md. (MedPage Today) -- An FDA advisory panel was split this week over whether Pfizer should be allowed to substitute an endpoint in its clinical trial testing sildenafil as a treatment for kids with pulmonary arterial hypertension.
CMS to Consider Evidence on Bone Growth Agent
WASHINGTON (MedPage Today) -- The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) will meet in September to consider available evidence for using bone morphogenetic protein (BMP) for a number of on-label and off-label uses.
Women Big Winners With Health Reform Law
(MedPage Today) -- An estimated 30 million women will be helped by the new healthcare reform law over the next 10 years, according to a report from The Commonwealth Fund.
Stalled Stem Cell Trial for Spine Injury Cleared Again
(MedPage Today) -- The on-again, off-again clinical trial of a human embryonic stem cell (hESC) therapy for spinal cord injury is on again, its sponsor said.
Number of Uninsured Varies Greatly by State
Massachusetts (MedPage Today) -- a state with a universal health insurance program -- has the nation's lowest rate of uninsured residents under age 65, at 7.8%, according to data released by the Census Bureau.
Reports Alert FDA to Possible Contamination
(MedPage Today) -- Over a seven-month period, manufacturers and distributors have reported 125 food safety issues directly to the FDA, most concerning Salmonella or allergens, the agency said.
Federal Panel Endorses Ticagrelor for ACS
ADELPHI, Md. (MedPage Today) -- An FDA advisory panel has voted overwhelmingly to recommend approval of AstraZeneca's investigational antiplatelet drug ticagrelor (Brilinta), saying it appears more effective than clopidogrel (Plavix) for patients with acute coronary syndrome who will be treated either medically or with PCI.
Eye Vitamin Recalled Over Reports of Choking
(MedPage Today) -- The manufacturers of a softgel supplement marketed as an eye vitamin issued a voluntary recall of the product due to a potential choking hazard.
Soft Endpoint Sought for Pediatric PAH Trial
(MedPage Today) -- An FDA advisory panel will revisit an increasingly familiar battleground this week, as it considers whether a drug sponsor can substitute a surrogate endpoint for a clinical outcome in a pediatric pulmonary arterial hypertension (PAH) trial.
Pharmacy Chain to Pay HHS $1 Million for Privacy Violations
(MedPage Today) -- The East Coast's largest drugstore chain, Rite Aid, settled a Health Insurance Portability and Accountability Act (HIPAA) privacy violation case with the Department of Health and Human Services (HHS) for $1 million.
FDA Panel Split on Medtronic Spine Device
(MedPage Today) -- GAITHERSBURG, Md. -- An FDA advisory panel was split over whether to recommend approval for an investigational Medtronic spine device called Amplify -- citing lack of data to prove the device's benefits outweigh its risks for degenerative disc disease patients.
FDA Panel to Vote on Blood Thinner Ticagrelor
WASHINGTON (MedPage Today) -- FDA reviewers said AstraZeneca's investigational antiplatelet ticagrelor (Brilinta) appears more effective than clopidogrel (Plavix) for patients with acute coronary syndrome, but expressed concern that the findings didn't hold up in a U.S. population.
Drugmaker Fights Approval of Generic Anticoagulant
(MedPage Today) -- Sanofi-aventis filed a lawsuit yesterday seeking to block sales of a generic version of its low-molecular-weight heparin product Lovenox (enoxaparin sodium injection) following the FDA's approval of the generic last week.
FDA Concerned with Cancer Rates for New Spine Device
WASHINGTON (MedPage Today) -- FDA reviewers said they were concerned with the increased number of cancer cases seen in degenerative disc disease patients implanted with an investigational Medtronic spine device compared with patients who underwent spinal fusion.

and precious time is immense. One redeeming feature in doing online course is the unhurried pace of learning which is a very efficacious method of learning. You can do your studies whenever you feel like it. Good broadband connection is all you need. There is no set time. Normally, you can finish the course in twelve months or if you are smart enough and want to have done with it as quickly as possible, there is provision for you to finish it in several months. When you have completed an online course, you can be employed with a medical office, a doctor, a clinic or a hospital where it is difficult to survive without the services of a medical biller. It is advisable to commence work with someone else and amass experience and knowledge in this sphere. Thereafter, you may set up your own business armed with the knowledge so garnered. Therefore, you can browse the Internet and find yourself a good institution where online courses are available. There are many such websites promoting such study courses.
This article is written by Mike

Here are some articles to start with..

Medicalbillingathome
By Mike
The Internet has brought onto the scene a new breed of jobs known as work at home jobs. There is a plethora of such jobs that have become very popular with the Internet users. Medical billing at Read more...

Medical Billing Certification
By Mike
Medical billing refers to the practice of submitting claims to insurance companies or various government entities in order to receive payment for services provided to a patient by a medical doctor or Read more...